Immunodeficiencies: injecting some safety into SCID gene therapy?

Gene Ther. 2006 May;13(9):741-3. doi: 10.1038/sj.gt.3302663.
No abstract available

Publication types

  • News

MeSH terms

  • Animals
  • Genetic Therapy / adverse effects
  • Genetic Therapy / methods*
  • Genetic Vectors
  • Humans
  • Lentivirus
  • Mice
  • Severe Combined Immunodeficiency / therapy*
  • Thymus Gland
  • ZAP-70 Protein-Tyrosine Kinase / deficiency

Substances

  • ZAP-70 Protein-Tyrosine Kinase